| P2093 | author name string | Wei Zhang | |
| | Jing Wang | |
| | Wei Ji | |
| | Xing Liu | |
| | Wuhan Xiao | |
| | Gang Ouyang | |
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| | Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor | Q24298032 |
| | Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage | Q24299098 |
| | Chk2 activates E2F-1 in response to DNA damage | Q24300634 |
| | Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation | Q24318303 |
| | TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival | Q24627319 |
| | Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex | Q24654714 |
| | A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 |
| | Retinoblastoma protein recruits histone deacetylase to repress transcription | Q28262144 |
| | Rb Interacts with Histone Deacetylase to Repress Transcription | Q28263985 |
| | Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein | Q29615931 |
| | E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells | Q33589421 |
| | E2F-1 Directly Regulates Thrombospondin 1 Expression | Q33728451 |
| | Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27. | Q33837015 |
| | p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. | Q33972469 |
| | Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. | Q34091273 |
| | Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. | Q34530199 |
| | p53 stabilization and transactivation by a von Hippel-Lindau protein | Q34567288 |
| | E2F1 pathways to apoptosis | Q34922303 |
| | Emerging roles of E2Fs in cancer: an exit from cell cycle control | Q35009182 |
| | The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. | Q35036600 |
| | The E2F family: specific functions and overlapping interests | Q35945854 |
| | Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein | Q36034460 |
| | Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice | Q36551258 |
| | Transcriptional and Nontranscriptional Functions of E2F1 in Response to DNA Damage | Q36584712 |
| | The von hippel-lindau tumor suppressor protein: an update | Q36999097 |
| | Multitasking by pVHL in tumour suppression | Q37002154 |
| | Cellular mechanisms of tumour suppression by the retinoblastoma gene. | Q37225340 |
| | Conserved functions of the pRB and E2F families | Q37249375 |
| | Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis | Q37506973 |
| | Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance | Q37776932 |
| | Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis | Q38299703 |
| | Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2. | Q38301658 |
| | E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. | Q38304702 |
| | Lysine methylation regulates E2F1-induced cell death | Q39684254 |
| | Regulation of E2F1 activity by acetylation | Q40387087 |
| | Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination | Q40416938 |
| | Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein | Q40656395 |
| | Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter | Q40718800 |
| | The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway | Q41148875 |
| | Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation | Q43099231 |
| | VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. | Q43455466 |
| | Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein | Q44043145 |
| | The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma | Q44043146 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 185-195 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | pVHL acts as a downstream target of E2F1 to suppress E2F1 activity | |
| P478 | volume | 457 | |